Development of Ulvan-Containing Liposomes as Antibacterial Drug Delivery Platforms
Development of Ulvan-Containing Liposomes as Antibacterial Drug Delivery Platforms
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Liposomes, due to their safety profile and targeting ability, are among the most studied nanocarriers as antimicrobial delivery systems. However, due to lack of stability and the non-specific interaction of liposomes with cells and proteins, their use is relatively limited. Aiming to overcome these drawbacks, it was envisaged that incorporation of...
Alternative Titles
Full title
Development of Ulvan-Containing Liposomes as Antibacterial Drug Delivery Platforms
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_20d5207cef49492a8b4d22eba3aa564e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_20d5207cef49492a8b4d22eba3aa564e
Other Identifiers
ISSN
2079-4983
E-ISSN
2079-4983
DOI
10.3390/jfb13040186
